Caribou Biosciences

Caribou Biosciences

Caribou Biosciences

Pioneering the revolutionary field of CRISPR-Cas genome editing to advance therapeutics, agricultural biotech, biological research, and industrial biotech.
Founded
2011
Raised
$32.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$30,000,000
Venture capital (Series B) - 2016
Heritage Group Novartis F-Prime Capital Partners +5
Undisclosed amount
Venture capital - 2015
Novartis
Team Size
10+
Employees
$30,000,000 Venture capital (Series B)
FinSMEs

Caribou Biosciences Completes $30M Series B Funding

Funding Science
Venture capital
GEN

GEN | News Highlights:Novartis Launches CRISPR Collaborations with Intellia, Caribou